Hewlett-Packard ties in Aspect's technology:
This article was originally published in Clinica
Executive Summary
Hewlett-Packard is to integrate Aspect Medical Systems' Bispectral Index (BIS) technology into its Viridia 24/265 and Viridia CMS patient monitors under a worldwide licensing agreement. Non-invasive BIS monitoring provides a direct measurement of the effects of anaesthesia on the brain, via a sensor placed on the forehead to capture EEG signals. Under the agreement, HP will assist in the distribution of Aspect's stand-alone A-2000 BIS monitor and BIS sensors outside the US. Separately, HP has announced that its test and measurement company, which is being spun-off from the computer and printer business, will be called Agilent Technologies.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.